In 2021, the American Medical Association issued an official policy statement calling for the cessation of ivermectin prescriptions for COVID-19

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

CDC and HHS leadership, research integrity, bioethics, regulatory appointments, e-cigarette regulation, and global health funding.